• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch
Shop

California Introduces New Bill to Decriminalize Psychedelics

Microdose NewsDesk by Microdose NewsDesk
December 19, 2022
in Law & Politics
Reading Time: 1 min read
A A
California Introduces New Bill to Decriminalize Psychedelics

California is once again trying to decriminalize psychedelics, as Sen. Scott Wiener re-introduces a psychedelics decrim bill, SB 58.

This is the second effort by the Californian Democrat to remove criminal penalties for psychedelics. Last year, SB 519, a similar decrim bill made decent progress through the legislature, being approved by several committees, before being shot down by an Appropriations Committee.

The new bill (SB 58) would decriminalize plant-based hallucinogens like psilocybin and DMT, as well as ibogaine and mescaline.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT

“Psychedelics have tremendous capacity to help people heal, but right now, using them is a criminal offense. These drugs literally save lives and are some of the most promising treatments we have for PTSD, anxiety, depression, and addiction.” – Sen. Wiener

Buy Verified Lasix

 

Continue on your trip...

Psylutions and the DEA

US Congress Adds Psychedelics Studies to Defense Bill

Enveric Granted US Patent for Psilocybin Derivatives

The bill is sponsored by the Heroic Hearts Project, a veteran advocacy group providing support for soldiers suffering PTSD using psychedelic therapy.

With recent decrim wins in Colorado, perhaps Weiner and his Californian supporters think the political timing is right to attempt to pass this bill again.

Let’s see how far it gets this time around.

 

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Decriminalization
Microdose NewsDesk

Microdose NewsDesk

Microdose's editorial department brings you the latest news and industry insights.

Next Post
ATAI Announces Fourth Quarter and Full Year 2021 Results

Atai Initiates Phase 2b Trial of RL-007 for Schizophrenia

Please login to join discussion

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.